Literature DB >> 23160589

Angioedema--assessment and treatment.

Eva H Rye Rasmussen1, Carsten Bindslev-Jensen, Anette Bygum.   

Abstract

BACKGROUND: Angioedema has numerous hereditary, acquired and iatrogenic causes. A number of studies show that angioedema is inadequately assessed and treated during its acute phase as well as in the follow-up period. We present an algorithm for the assessment and treatment of patients with angioedema. KNOWLEDGE BASE: The article is based on a literature search in PubMed, a review of bibliographies and the authors' clinical experience and research.
RESULTS: The majority of angioedema patients have accompanying urticaria. Pathophysiologically, angioedemas are divided into histaminergic and non-histaminergic forms. In a large group of patients no positive trigger is identified. On assessment in hospital the most frequently identified cause is drug intake, normally angiotensin-converting-enzyme inhibitors and NSAIDs , while allergic/pseudoallergic and idiopathic reactions are more commonly seen in general practice. There are a number of rare causes of angioedema, all of which are important to keep in mind. The acute and prophylactic treatment will depend on the subtype of angioedema and is best provided through cross-disciplinary collaboration.
INTERPRETATION: Angioedema is a potentially life-threatening condition and should be assessed and treated systematically. It is important to remember that angioedema is either histaminergic or non-histaminergic, as the treatment of the two types is different.

Entities:  

Mesh:

Year:  2012        PMID: 23160589     DOI: 10.4045/tidsskr.12.0470

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  8 in total

1.  Isolated oedema of the uvula induced by intense snoring and ACE inhibitor.

Authors:  Eva Rye Rasmussen; Kristianna Mey; Anette Bygum
Journal:  BMJ Case Rep       Date:  2014-08-21

2.  Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital.

Authors:  Amalie Hartvig Pall; Anne Fog Lomholt; Christian von Buchwald; Anette Bygum; Eva Rye Rasmussen
Journal:  J Asthma Allergy       Date:  2020-07-17

3.  Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: a bradykinin receptor antagonist.

Authors:  Sarah Ostenfeld; Anette Bygum; Eva Rye Rasmussen
Journal:  BMJ Case Rep       Date:  2015-10-23

Review 4.  Patient-reported Outcome Measures for Angioedema: A Literature Review.

Authors:  Anna Trier Heiberg Brix; Henrik Balle Boysen; Karsten Weller; Teresa Caballero; Anette Bygum
Journal:  Acta Derm Venereol       Date:  2021-05-19       Impact factor: 3.875

5.  Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.

Authors:  G Sussman; M Abuzakouk; F Bérard; W Canonica; H Oude Elberink; A Giménez-Arnau; C Grattan; K Hollis; S Hunter; A Knulst; J-P Lacour; C Lynde; A Marsland; D McBride; M Maurer; A Nakonechna; J Ortiz de Frutos; M Reynolds; C Sweeney; H Tian; K Weller; D Wolin; M-M Balp
Journal:  Allergy       Date:  2018-08       Impact factor: 13.146

6.  The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema.

Authors:  Thorbjørn Hermanrud; Nicolaj Duus; Anette Bygum; Eva Rye Rasmussen
Journal:  Case Rep Emerg Med       Date:  2016-03-31

7.  Sirolimus-induced severe small bowel angioedema: A case report.

Authors:  Hui Yang; Wei Wang; Xiaopeng Hu; Xiaodong Zhang; Lihong Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

8.  Angioedema without wheals: a clinical update.

Authors:  Okan Gülbahar
Journal:  Balkan Med J       Date:  2021-03       Impact factor: 2.021

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.